Catalent
Quick Facts: Catalent
- Signal Score
- 76.2/100 (as of 2026-11-12)
- Quality Compliance
- 77.5/100 — OAI classification at Bloomington (2025-07-14) — CRITICAL
- Headquarters
- Tampa, FL
- Website
- https://catalent.com
- Modalities
- Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed — 11 partnership signals in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Catalent
Acquired by Novo Holdings for $16.5B.
Signal Score & Pillar Breakdown
Catalent FDA Inspection History
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2026-05-22 |
Catalent Pharma Solutions LLC
Morrisville, North Carolina
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2026-04-24 |
Catalent Indiana, LLC
Bloomington, Indiana
Facility-linked
|
Drug Quality Assurance | Not posted | Official Action Indicated (OAI) |
| 2025-12-17 |
Catalent Pharma Solutions, LLC
Philadelphia, Pennsylvania
Company-level
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2025-10-24 |
Catalent Greenville Inc
Greenville, North Carolina
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-07-14 |
Catalent Indiana, LLC
Bloomington, Indiana
Facility-linked
|
Drug Quality Assurance | Not posted | Official Action Indicated (OAI) |
| 2025-06-09 |
Catalent Micron Technologies, Inc.
Malvern, Pennsylvania
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2025-06-05 |
Catalent Pharma Solutions, LLC
Philadelphia, Pennsylvania
Company-level
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2025-04-22 |
Catalent Pharma Solutions, LLC
Winchester, Kentucky
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-04-09 |
Catalent Maryland, Inc.
Baltimore, Maryland
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Yes | Voluntary Action Indicated (VAI) |
| 2024-11-15 |
Catalent Maryland Inc
Harmans, Maryland
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2024-10-10 |
Catalent Pharma Solutions Limited
Swindon
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2024-05-30 |
Catalent Pharma Solutions, LLC
Saint Petersburg, Florida
Company-level
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2024-05-24 |
Catalent Pharma Solutions LLC
Morrisville, North Carolina
Facility-linked
|
Blood and Blood Products | Yes | Voluntary Action Indicated (VAI) |
| 2024-01-31 |
Catalent Greenville Inc
Greenville, North Carolina
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2023-11-15 |
Catalent Indiana, LLC
Bloomington, Indiana
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2023-06-15 |
Catalent U.K. Swindon Zydis Limited
Swindon
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2023-03-10 |
Catalent Maryland Inc
Harmans, Maryland
Facility-linked
|
Vaccines and Allergenic Products | Not posted | Voluntary Action Indicated (VAI) |
| 2023-01-24 |
Catalent Maryland Inc
Harmans, Maryland
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2023-01-11 |
Catalent Pharma Solutions, LLC
Winchester, Kentucky
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2022-12-15 |
Catalent Pharma Solutions LLC
Morrisville, North Carolina
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2022-09-01 |
Catalent Indiana, LLC
Bloomington, Indiana
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2022-06-22 |
Catalent Micron Technologies, Limited
Dartford
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2022-03-04 |
Catalent CTS, LLC
Kansas City, Missouri
Company-level
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2021-11-17 |
Catalent Maryland Inc
Harmans, Maryland
Facility-linked
|
Vaccines and Allergenic Products | Not posted | Voluntary Action Indicated (VAI) |
| 2026-01-30 |
Catalent Pharma Solutions, LLC
Saint Petersburg, Florida
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Catalent FDA 483 Findings 22 observations · 2022-12-15 → 2026-05-22 ?
By subsystem
By severity
- 4 — Serious: 1
- 3 — Moderate: 5
- 2 — Minor: 16
- Repeat observations: 0
Most severe findings
-
Sterility/pyrogens - test methods written, followed
"Test procedures relative to appropriate laboratory testing for pyrogens are not written."
-
Written program not followed
"The written stability testing program is not followed."
-
Microbiological testing
"Each batch of drug product required to be free of objectionable microorganisms is not tested through appropriate laboratory testing."
Catalent EMA GMP Compliance 21 certificates
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2026_0170 | Catalent Germany Schorndorf GmbH | Germany | 2026-05-22 | COMPLIANT |
| DE_BW_01_GMP_2026_0171 | Catalent Germany Schorndorf GmbH | Germany | 2026-05-22 | COMPLIANT |
| IT/110/H/2026 | Catalent Anagni S.r.l. | Italy | 2026-04-15 | COMPLIANT |
| 2026_HPF_FR_061 | Catalent France Limoges S.A.S. | France | 2026-01-16 | COMPLIANT |
| 2026_HPF_FR_060 | Catalent France Limoges S.A.S. | France | 2026-01-16 | COMPLIANT |
| DE_NW_03_GMP_2026_0037 | Catalent Duesseldorf GmbH | Germany | 2025-09-11 | COMPLIANT |
| BE/GMP/2024/061 | Catalent Gosselies | Belgium | 2024-05-27 | COMPLIANT |
| BE/GMP/2024/060 | Catalent Gosselies | Belgium | 2024-05-27 | COMPLIANT |
| DE_BW_01_GMP_2024_0147 | Catalent Germany Schorndorf GmbH | Germany | 2024-04-12 | COMPLIANT |
| DE_BW_01_GMP_2024_0177 | Catalent Germany Schorndorf GmbH | Germany | 2024-04-12 | COMPLIANT |
| IT/104/H/2024 | Catalent Italy S.p.A. | Italy | 2024-03-22 | COMPLIANT |
| IT/98/H/2026 | Catalent Italy S.p.A. | Italy | 2024-03-22 | COMPLIANT |
| IT/103/H/2026 | Catalent Italy S.p.A. | Italy | 2024-03-22 | COMPLIANT |
| BE/GMP/2024/022 | Catalent Gosselies PS | Belgium | 2024-03-15 | COMPLIANT |
| BE/GMP/2024/021 | Catalent Gosselies PS | Belgium | 2024-03-15 | COMPLIANT |
| IT/234/H/2024 | Catalent Anagni S.r.l. | Italy | 2024-02-23 | COMPLIANT |
| DE_BW_01_GMP_2024_0042 | Catalent Germany Eberbach GmbH | Germany | 2024-02-02 | COMPLIANT |
| DE_BW_01_GMP_2024_0040 | Catalent Germany Eberbach GmbH | Germany | 2024-02-02 | COMPLIANT |
| BE/GMP/2020/003 | Catalent Belgium SA | Belgium | 2020-01-20 | COMPLIANT |
| BE/GMP/2020/007 | Catalent Belgium SA | Belgium | 2020-01-20 | COMPLIANT |
| BE/GMP/2020/013 | Catalent Belgium SA | Belgium | 2020-01-20 | COMPLIANT |
Catalent MHRA GMP Compliance 18 certificates
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA 14023 Insp GMP/IMP 14023/4574-0025[H] | CATALENT UK SWINDON ZYDIS LIMITED | SWINDON SN5 8RU | 2026-05-12 | COMPLIANT |
| UK MIA(IMP) 14023 Insp GMP/IMP 14023/4574-0025[I] | CATALENT UK SWINDON ZYDIS LIMITED | SWINDON SN5 8RU | 2026-05-12 | COMPLIANT |
| UK MIA 5451 Insp GMP/IMP 5451/16389-0023[H] | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2025-06-26 | COMPLIANT |
| UK MIA(IMP) 5451 Insp GMP/IMP 5451/16389-0023[I] | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2025-06-26 | COMPLIANT |
| UK API 5451 Insp GMP/IMP 5451/16389-0023 | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2025-06-26 | COMPLIANT |
| UK MIA 14023 Insp GMP 14023/4574-0024[H] | CATALENT UK SWINDON ZYDIS LIMITED | SWINDON SN5 8RU | 2024-10-09 | COMPLIANT |
| UK MIA(IMP) 14023 Insp GMP/IMP 14023/4574-0022[I] | CATALENT UK SWINDON ZYDIS LIMITED | SWINDON SN5 8RU | 2023-06-13 | COMPLIANT |
| UK MIA 5451 Insp GMP/IMP 5451/16389-0021[H] | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2022-06-21 | COMPLIANT |
| UK ManA 5451 Insp GMP 5451/16389-0022[V] | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2022-06-21 | COMPLIANT |
| UK MIA 32496 Insp GMP 5451/16389-0019[H] | CATALENT MICRON TECHNOLOGIES LIMITED | DARTFORD DA2 6QY | 2021-03-29 | COMPLIANT |
| UK GMP 20656 Insp GMP 33168/460035-0005[H] | CATALENT PHARMA SOLUTIONS LLC | 33716 | 2017-03-27 | COMPLIANT |
| UK GMP 20657 Insp GMP 20657/873857-0004[H] | CATALENT PHARMA SOLUTIONS LLC | 40391 | 2017-03-13 | COMPLIANT |
| UK GMP 20656 Insp GMP 20656/430174-0010[H] | CATALENT PHARMA SOLUTIONS LLC | NEW JERSEY 08873 | 2016-10-17 | COMPLIANT |
| UK GMP 20656 Insp GMP 20656/430168-0005[H] | CATALENT PHARMA SOLUTIONS INCORPORATED | 19114 | 2015-10-05 | COMPLIANT |
| UK GMP 20656 Insp GMP/IMP 20656/430174-0009 [V] | CATALENT PHARMA SOLUTIONS LLC | NEW JERSEY 08873 | 2013-09-17 | COMPLIANT |
| UK GMP 20657 Insp GMP 27385/113084-0005[H] | CATALENT PHARMA SOLUTIONS | 64137 | 2013-02-25 | COMPLIANT |
| UK API 18653 Insp GMP 18653/2970147-0002 | CATALENT MICRON TECHNOLOGIES INCORPORATED | 19355 | 2011-03-28 | COMPLIANT |
| UK GMP 33624 Insp GMP 33624/542366-0001[H] | CATALENT PHARMA SOLUTIONS | PR-00791 | 2009-02-13 | COMPLIANT |
Japan-accredited overseas site (PMDA)
biologics, cell and gene therapy (CGT), general (non-sterile), packaging/storage only, CGT packaging/storage only · 12 sites
- Eberbach, Germany · Catalent Germany Eberbach GmbH — general (non-sterile) · valid to Dec 31, 2026 renewal filed
- Schorndorf, Germany · Catalent Germany Schorndorf GmbH — general (non-sterile) · valid to Oct 30, 2031
- Dartford, United Kingdom · Catalent Micron Technologies Ltd. — general (non-sterile) · valid to Jul 7, 2030
- Swindon, United Kingdom · Catalent U.K. Swindon Zydis Limited — general (non-sterile) · valid to Mar 25, 2027 renewal due
- Baltimore, United States · Catalent Maryland, Inc. — cell and gene therapy (CGT) · valid to Jul 22, 2029
- Greenville, United States · Catalent Greenville, Inc. — general (non-sterile) · valid to Aug 28, 2028
- Harmans, United States · Catalent Maryland, Inc. — cell and gene therapy (CGT) · valid to Jul 22, 2029
- Kansas City, United States · Catalent CTS, LLC — general (non-sterile), packaging/storage only · valid to May 21, 2028
- Malvern, United States · Catalent Micron Technologies, Inc. — general (non-sterile) · valid to Jul 7, 2030
- Morrisville, United States · Catalent Pharma Solutions, LLC — general (non-sterile) · valid to Mar 20, 2029
- Philadelphia, United States · Catalent Pharma Solutions — biologics, packaging/storage only, CGT packaging/storage only · valid to Jan 22, 2028
- St. Petersburg, United States · Catalent Pharma Solutions, LLC — general (non-sterile) · valid to Sep 1, 2028
Previously accredited (cancelled) · 2
- Schorndorf, Germany · Catalent Germany Schorndorf GmbH — general (non-sterile) · cancelled Feb 23, 2016
- St. Petersburg, United States · Catalent Pharma Solutions, LLC — general (non-sterile) · cancelled Jan 23, 2013
No longer on PMDA's current list. Shown for history only; not used in search tags.
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity 311 open roles Beta
- 32 manufacturing and operations openings at Madison, Wisconsin, United States of America. That fits staffing of production shifts; on its own it doesn't show new capacity.
- 8 manufacturing and operations openings at Greenville, North Carolina, United States of America. That fits staffing of production shifts; on its own it doesn't show new capacity.
- 12 job titles mention mRNA (Madison, Wisconsin, United States of America). That points to mRNA work there as of Nov 20, 2026, not to its size or stage.
32 mfg/ops · 13 QA/QC · 9 PD/MSAT · 6 eng. · 4 other 64
15 mfg/ops · 5 QA/QC · 3 PD/MSAT · 9 eng. · 2 other 34
3 mfg/ops · 5 QA/QC · 10 PD/MSAT · 4 eng. · 9 other 31
8 mfg/ops · 2 QA/QC · 4 PD/MSAT · 4 other 18
4 mfg/ops · 4 QA/QC · 2 PD/MSAT · 1 eng. · 5 other 16
8 mfg/ops · 3 QA/QC · 2 PD/MSAT · 2 other 15
· 2 PD/MSAT · 7 eng. · 4 other 13